Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs MAIA Biotechnology, Inc. (MAIA)

Cognition Therapeutics, Inc. and MAIA Biotechnology, Inc. are both Biotechnology companies. Cognition Therapeutics, Inc. and MAIA Biotechnology, Inc. are of similar size ($69.7M and $69.2M). Across the 8 metrics below, Cognition Therapeutics, Inc. leads on 7 and MAIA Biotechnology, Inc. on 1.

Valuation

Metric CGTX MAIA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.00 3.23 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (23.29%) (57.25%) (33.15%)
Free cash flow yield (26.75%) (33.75%) (25.50%)

Profitability

Metric CGTX MAIA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (83.76%) (218.68%) (56.36%)
Return on assets (57.33%) (136.67%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGTX MAIA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 62.79% 33.33% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX MAIA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.03 4.51 4.72
Net debt to EBITDA 0.78 0.36 0.96

Dividend

Metric CGTX MAIA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGTX MAIA Biotechnology median
Market cap 69.67m 69.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack